Instituto Clínico Oncológico del Sur

Temuco 4810469

0 studies enrolling now · 2 studies all time

What they study most

Ovarian Cancer, Soft Tissue Sarcoma

Studies at this site

• Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse — Stopped early
• Study of Palifosfamide-tris in Combination With Doxorubicin in Patients With Front-line Metastatic Soft Tissue Sarcoma — Completed